DREGX
Price
$58.80
Change
-$0.29 (-0.49%)
Updated
Sep 11 closing price
Net Assets
4.91B
RNWHX
Price
$107.05
Change
-$0.71 (-0.66%)
Updated
Sep 11 closing price
Net Assets
90.01B
Interact to see
Advertisement

DREGX vs RNWHX

DREGX vs RNWHX Comparison Chart in %
View a ticker or compare two or three
VS
DREGX vs. RNWHX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DREGX is a StrongBuy and RNWHX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWHX has more cash in the bank: 90B vs. DREGX (4.91B). DREGX pays higher dividends than RNWHX: DREGX (1.38) vs RNWHX (1.15). DREGX was incepted earlier than RNWHX: DREGX (29 years) vs RNWHX (11 years). DREGX (1.15) is less costly to investors than RNWHX (0.72). DREGX is a more actively managed with annual turnover of: 137.00 vs. RNWHX (46.00). RNWHX has a lower initial minimum investment than DREGX: RNWHX (250) vs DREGX (10000). DREGX annual gain was more profitable for investors over the last year : 32.59 vs. RNWHX (17.19). DREGX return over 5 years is better than : 20.12 vs. RNWHX (17.68).
DREGXRNWHXDREGX / RNWHX
Total Expense Ratio1.150.72160%
Annual Report Gross Expense Ratio1.150.72160%
Fund Existence29 years11 years-
Gain YTD23.83116.447145%
Front LoadN/AN/A-
Min. Initial Investment100002504,000%
Min. Initial Investment IRA2000N/A-
Net Assets4.91B90B5%
Annual Yield % from dividends1.381.15120%
Returns for 1 year32.5917.19190%
Returns for 3 years82.8453.84154%
Returns for 5 years20.1217.68114%
Returns for 10 years112.18111.44101%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FLPEX46.310.28
+0.61%
Fidelity Advisor Low-Priced Stock C
FACDX64.25N/A
N/A
Fidelity Advisor Health Care A
EXHAX26.61N/A
N/A
Manning & Napier Pro-Blend Max Term S
LMCFX35.98N/A
N/A
Lord Abbett Mid Cap Stock F
MSAWX22.51N/A
N/A
Morgan Stanley Inst Asia Opp C